Quantbot Technologies LP Cerus Corp Transaction History

Quantbot Technologies LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.25 - $2.35 $18,451 - $34,688	14,761 New	14,761 $31,000
Q2 2023 Aug 08, 2023	BUY	$1.79 - $2.9 $26,153 - $42,371	14,611 Added 52.44%	42,474 $104,000
Q1 2023 May 12, 2023	BUY	$2.65 - $3.81 $73,836 - $106,158	27,863 New	27,863 $82,000
Q1 2022 May 16, 2022	SELL	$4.81 - $6.99 $144,781 - $210,399	-30,100 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$5.97 - $7.93 $22,244 - $29,547	3,726 Added 14.13%	30,100 $204,000
Q3 2021 Nov 09, 2021	BUY	$4.79 - $6.68 $86,368 - $120,447	18,031 Added 216.12%	26,374 $160,000
Q2 2021 Aug 12, 2021	SELL	$5.35 - $6.35 $598,493 - $710,361	-111,868 Reduced 93.06%	8,343 $49,000
Q1 2021 May 14, 2021	BUY	$5.68 - $7.87 $227,932 - $315,815	40,129 Added 50.11%	120,211 $722,000
Q4 2020 Feb 12, 2021	BUY	$5.25 - $8.56 $418,220 - $681,898	79,661 Added 18921.85%	80,082 $554,000
Q3 2020 Nov 16, 2020	BUY	$5.78 - $7.47 $2,433 - $3,144	421 New	421 $2,000
Q1 2018 May 11, 2018	SELL	$3.56 - $5.74 $6,098 - $9,832	-1,713 Closed	0 $0
Q4 2017 Feb 12, 2018	SELL	$2.76 - $3.95 $1,104 - $1,580	-400 Reduced 18.93%	1,713 $5,000
Q3 2017 Nov 07, 2017	BUY	$2.22 - $2.73 $4,690 - $5,768	2,113	2,113 $5,000

156

147M

84.2K

55.5K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $317M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.